Pricing, availability, eligibility, and regulatory status can change
Safety and Efficacy of Once-Weekly Dulaglutide Versus Sitagliptin After 2 Years in Metformin-Treated Patients With Type 2 Diabetes (AWARD-5): A Randomized, Phase III Study
But heres the kickera massive study tracking over 120,000 people found that most quit taking these medications within two years
Standard Protocol (Targeted Repair/Systemic Research): A dosage of 500 mcg per day, often split into two doses of 250 mcg each (one in the morning, one at night), is the most prevalent protocol we see
B12 deficiency prevention during GLP-1 therapy This is the more serious reason for B12 inclusion, and it is one that many patients are not informed about
it also increased the proportion of slow wave (deep) and REM sleep while decreasing lighter NREM sleep stages